A detailed history of Fmr LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,104,099 shares of PTCT stock, worth $48.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,104,099
Previous 1,727,062 36.07%
Holding current value
$48.9 Million
Previous $50.2 Million 32.8%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$24.69 - $40.12 $15.4 Million - $25 Million
-622,963 Reduced 36.07%
1,104,099 $33.8 Million
Q1 2024

May 13, 2024

SELL
$24.15 - $31.95 $2.11 Million - $2.79 Million
-87,359 Reduced 4.81%
1,727,062 $50.2 Million
Q4 2023

Feb 13, 2024

SELL
$18.07 - $29.37 $120 Million - $195 Million
-6,650,963 Reduced 78.57%
1,814,421 $50 Million
Q3 2023

Nov 13, 2023

SELL
$22.41 - $41.99 $40.1 Million - $75.1 Million
-1,787,740 Reduced 17.44%
8,465,384 $190 Million
Q2 2023

Aug 11, 2023

BUY
$40.4 - $59.1 $27.1 Million - $39.6 Million
669,956 Added 6.99%
10,253,124 $417 Million
Q1 2023

May 11, 2023

SELL
$38.16 - $48.86 $45.8 Million - $58.6 Million
-1,199,138 Reduced 11.12%
9,583,168 $464 Million
Q4 2022

Feb 13, 2023

BUY
$33.53 - $54.79 $1.72 Million - $2.8 Million
51,162 Added 0.48%
10,782,306 $412 Million
Q3 2022

Nov 10, 2022

BUY
$41.85 - $53.85 $1.27 Million - $1.63 Million
30,307 Added 0.28%
10,731,144 $539 Million
Q2 2022

Aug 12, 2022

SELL
$25.6 - $45.23 $673,484 - $1.19 Million
-26,308 Reduced 0.25%
10,700,837 $429 Million
Q1 2022

May 13, 2022

BUY
$33.33 - $44.6 $4.08 Million - $5.46 Million
122,460 Added 1.15%
10,727,145 $400 Million
Q4 2021

Feb 14, 2022

BUY
$35.36 - $41.86 $493,413 - $584,114
13,954 Added 0.13%
10,604,685 $422 Million
Q3 2021

Nov 15, 2021

BUY
$37.01 - $44.74 $826,988 - $999,715
22,345 Added 0.21%
10,590,731 $394 Million
Q2 2021

Aug 13, 2021

BUY
$37.95 - $49.37 $401 Million - $522 Million
10,568,386 New
10,568,386 $447 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.17B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.